How much protein should I eat while taking a GLP-1 medication?
No expert body has published a GLP-1 specific target. The figures circulating are borrowed from weight-loss and older-adult guidance, typically 1.2 to 1.6 g per kilogram of body weight a day. That is a reasonable extrapolation from populations that resemble this one, and it is an extrapolation, so your prescriber sets your number.
Key takeaways
- There is no established GLP-1 specific protein recommendation. Anyone stating one with confidence is extrapolating.
- The figures in circulation come from weight-loss trials and older-adult guidance, which are the closest available evidence.
- That usually lands between 1.2 and 1.6 g per kilogram of body weight a day for most people.
- The target is per kilogram, so it falls as you do. Recalculate every few months rather than carrying the first number.
- Your prescriber has your history and this page does not. The number here is reference material, not a prescription.
Start with the part most pages skip: no expert body has published a protein recommendation specifically for people taking these medications. Anyone giving you a confident GLP-1 number is borrowing it from somewhere else.
That is not a reason to ignore the question. It is a reason to know where the number came from.
Where the figures actually come from
| What it says | How closely it fits | |
|---|---|---|
| Weight-loss trials | 1.2 to 1.6 g/kg preserved more lean mass in a deficit | Close: this is a deficit, and a large one |
| Older-adult guidance | 1.0 to 1.2 g/kg from 65, higher with illness | Close for anyone over 60, which is a lot of this group |
| Sports nutrition | 1.4 to 2.0 g/kg while training | Fits the part of this group that lifts, and not the rest |
| GLP-1 research | Nothing on protein targets | There is no row here, and that is the point |
The extrapolation is reasonable. Rapid weight loss with a substantial lean-mass component is exactly the situation the first two rows were written for. It is still an extrapolation, and it is not what a guideline is.
Why the question comes up at all
In the body composition analysis of the tirzepatide obesity trial, roughly three quarters of the weight lost was fat and roughly one quarter was lean mass.1
The clause that gets dropped from the headlines is the important one: that ratio was broadly similar in the placebo group. This is what substantial weight loss looks like in general, not something distinctive the drug does to muscle. What is distinctive is the scale and the speed, which is why the ratio matters more here than in an ordinary diet.
The second reason is mechanical. These medications work by reducing appetite, and eating less of everything means eating less protein. So the intake that protects lean mass is the one that gets harder exactly when it starts to matter more.
The arithmetic
The recommendations are per kilogram of body weight, which has two consequences people miss.
| Body weight | 1.2 g/kg | 1.6 g/kg |
|---|---|---|
| 70 kg / 154 lb | 84 g | 112 g |
| 85 kg / 187 lb | 102 g | 136 g |
| 100 kg / 220 lb | 120 g | 160 g |
| 115 kg / 253 lb | 138 g | 184 g |
Your number falls as you do. Somebody starting at 115 kg and reaching 85 kg has gone from 138 g to 102 g at the same rate. Carrying the starting figure forward is not harmful and it is no longer what the recommendation says.
Scaling off a high starting weight overshoots. Targets calculated from total body weight at a high BMI produce numbers most people cannot eat, which is why an adjusted body weight is standard practice clinically. If a calculator has told you 190 g, that is worth questioning rather than attempting.
Our calculator asks whether you are taking a GLP-1 and shows which recommendation the result came from, so you can take it to somebody who knows your history.
Protein is half of the answer
The research on preserving lean mass pairs protein with resistance training almost without exception, and the expert groups for older adults recommend exercise alongside the higher intake rather than instead of it.2
Two or three sessions a week that load the major muscle groups is the usual figure. What that looks like on a GLP-1, including on the weeks after a dose increase, is its own question.
The practical difficulty is not knowing the number, it is reaching it on a day when nothing appeals. What to eat when appetite is low is the page for that.
The line this page does not cross
These are prescription medications and this is general reference material, not medical advice. Your protein target is a decision for the clinician who prescribed yours, particularly if you have reduced kidney function, liver disease, or any condition where protein intake is already managed as part of your care.
If you are losing weight faster than expected, struggling to eat, or noticing weakness, that is a conversation with your prescriber rather than an adjustment to a number on a website.
More questions about GLP-1
Is there an official protein recommendation for people on a GLP-1?
Not from the major expert bodies. The recommendations that exist cover healthy adults, older adults and people losing weight, and the GLP-1 situation resembles the last two closely enough that those figures are applied to it. That is a defensible extrapolation and it is not the same thing as a guideline.
Where does the 1.6 g/kg figure come from?
It comes from sports nutrition and muscle-preservation research rather than from any GLP-1 study. The number is close to where protein supplementation stopped adding fat-free mass in a large meta-analysis of resistance training. It is a sensible upper anchor and it was not derived on this population.
What if I cannot eat that much?
That is common and it is worth raising with your prescriber rather than pushing through. Appetite suppression is the mechanism the medication works by, so struggling to eat is not a failure of willpower. There are practical approaches, and there is also a point at which intake being too low is a clinical matter.
References
- Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight
- Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group
- Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials
- A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults